Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Microbot Medical Inc (NQ: MBOT ) 1.020 +0.020 (+2.00%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Microbot Medical Inc < Previous 1 2 3 4 5 6 Next > Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher May 22, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded down 0.20% to 33,359.71 while the NASDAQ rose 0.47% to 12,717.37. The S&P... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 22, 2023 Via Benzinga Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians May 22, 2023 A team of six leading European interventional radiologists used the LIBERTY® Surgical Robotic System and performed a total of 48 catheterizations From Microbot Medical Inc. Via GlobeNewswire Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases May 18, 2023 Company will enable focus on its LIBERTY technology through the introduction of the Core Business Focus Program coupled with cost restructuring to support it From Microbot Medical Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 18, 2023 Via Benzinga Zscaler To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday May 09, 2023 Stifel raised the price target for XPO, Inc. (NYSE: XPO) from $48 to $51. Stifel analyst J. Bruce Chan downgraded the stock from Buy to Hold. XPO shares fell 1.5% to $47.72 in pre-market trading. Via Benzinga Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System May 08, 2023 Distinguished publisher and lecturer, Interventional Radiologist Prof. Francisco Cesar Carnevale Expected to Perform the World’s First Clinical Cases at the Prestigious Institute of Radiology at the... From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces Final Data From Its Recent Animal Study May 05, 2023 Data supports next regulatory steps for the LIBERTY Robotic System From Microbot Medical Inc. Via GlobeNewswire Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization May 03, 2023 95% success rate of reaching pre-determined vascular target with no intraoperative complications presented during pre-clinical studies From Microbot Medical Inc. Via GlobeNewswire Gerry O’Sullivan, the Latest Member to Join Microbot Medical’s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases March 23, 2023 From Microbot Medical Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday April 14, 2023 On Friday, 127 companies set new 52-week lows. Via Benzinga Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to March 16, 2023 Internationally Recognized Academic Leader Awarded the National Institute for Health Research (NIHR) Research Rising Star Award, and Cardiovascular and Interventional Radiology (CVIR) Editors Medal From Microbot Medical Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Monday April 03, 2023 On Monday, 76 companies set new 52-week lows. Via Benzinga Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board March 13, 2023 Internationally Recognized and Awarded Interventional Radiologist Enhances Depth of Expertise as the LIBERTY® Robotic System Races Towards Regularity and Commercialization Objectives From Microbot Medical Inc. Via GlobeNewswire Microbot Medical’s Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY® Robotic System During Podium Presentation at Prestigious Robotics Conference March 09, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System March 02, 2023 Engagement with Interventional Radiologists Reaches Highest Level Yet as Company Continues to Progress Through Regulatory and Clinical Phases; Company Seeking to Create Interest and Anticipation for... From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting February 28, 2023 Continues to Raise Awareness of the LIBERTY® Robotic System Ahead of Commercialization Plans From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Expands its Geographic Presence to South America with the Addition of Francisco C. Carnevale, MD, PhD, FSIR to its Scientific Advisory Board February 27, 2023 Increases Key Opinion Leaders to 13 Throughout the Americas, Israel, and Europe to Support the Company’s Next Regulatory and Commercialization Paths for the LIBERTY® Robotic System From Microbot Medical Inc. Via GlobeNewswire Microbot Medical’s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan February 23, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series January 31, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next ‘Access-Ability Live by MBOT’ Webinar January 06, 2023 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series December 14, 2022 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel December 08, 2022 Pace of Jurisdictional Allowances Parallels Pre-Clinical and Regulatory Progress From Microbot Medical Inc. Via GlobeNewswire Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance November 18, 2022 Advanced Features of Remote Controller Specifically Developed to Deliver an Enhanced User Experience During Endovascular Procedures From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space November 15, 2022 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System November 03, 2022 Corresponding Application Previously Granted in the U.S. as the Company Continues to Create Global Barriers to Entry for its Novel Technology From Microbot Medical Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Tuesday November 01, 2022 On Tuesday, 85 stocks hit new 52-week lows. Via Benzinga Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe’s Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board October 31, 2022 From Microbot Medical Inc. Via GlobeNewswire Microbot Medical Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules October 25, 2022 From Microbot Medical Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session October 21, 2022 Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 33.1% to $0.2 during Friday's pre-market session. The company's market cap stands at $10.4 million. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.